Zhou, L., Wang, B., Li, P., Lu, Y., Ye, S., Li, S., Liang, A. (2025). Glofitamab effectively bridging CD19-specific CAR T- cell therapy while maintaining safety in patients with refractory DLBCL. Blood. https://doi.org/10.1182/blood-2025-7265